Tardive Dyskinesia Awareness Week.
The resolution highlights the alarming statistic that approximately 60 percent of the estimated 800,000 adults living with TD in the U.S. remain undiagnosed, which underscores the importance of early intervention. The Senate encourages education and awareness initiatives for healthcare providers and patients to help ensure that those at risk of TD receive appropriate screenings and interventions. By promoting Tardive Dyskinesia Awareness Week, this resolution aims to improve the quality of life for those affected by the condition and reduce the associated stigma.
Senate Concurrent Resolution No. 68, introduced by Senator Blakespear, seeks to declare the week of May 5, 2025, as Tardive Dyskinesia Awareness Week. This resolution aims to raise awareness about Tardive Dyskinesia (TD), a condition characterized by uncontrollable and repetitive movements attributed primarily to prolonged antipsychotic use. As the usage of these medications rises for managing severe mental illnesses such as bipolar disorder and schizophrenia, the resolution emphasizes the growing need for awareness and early screening of TD symptoms among those prescribed these medications.
While SCR 68 is intended to foster understanding and support for individuals with TD, potential points of contention may arise concerning the healthcare system's capacity to implement routine screenings recommended by the American Psychiatric Association. There may be discussions about access to healthcare, especially for marginalized communities identified as being at higher risk of TD, including those over 55 years old and individuals with mood or substance use disorders. Additionally, the resolution’s calls for education and awareness may prompt debates on funding and resources necessary for effective outreach.